Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

394
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026
Same author

Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies.

Clinical lung cancer·2026
Same author

Trends in lung cancer incidence by sex, age, tumour stage, and histological subtype in Bavaria, 2006-2023: A registry-based study.

Cancer epidemiology·2026
Same author

MRI for Lung Cancer Management: Any Closer to Clinical Application?

Journal of magnetic resonance imaging : JMRI·2026
Same author

A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM Framework.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study.

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

["PneumoNEXT - Continuing Education, Exchange, The Future": A pilot project to support the next generation of pulmonologists].

Pneumologie (Stuttgart, Germany)·2026
Same journal

Outcomes and risk factors for mortality in patients with pulmonary non-tuberculous mycobacterial infections: A single-center retrospective cohort study.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[ROSE using Van Gogh microscopy in interventional pulmonology].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Comparative analysis of drug therapy for fibrotic interstitial lung diseases based on results of phase 3 study].

Pneumologie (Stuttgart, Germany)·2026
Same journal

Catamenial pneumothorax complicated by massive right diaphragmatic hernia with solid organ herniation.

Pneumologie (Stuttgart, Germany)·2026
Same journal

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Related Experiment Video

Updated: Aug 5, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K

[Increasing dyspnoea and intermittent joint suffering].

Nikolas Malte Lehnert1, Jürgen Behr1, Amanda Tufman1

  • 1Medizinische Klinik V, LMU Faculty of Medicine, München, Deutschland.

Pneumologie (Stuttgart, Germany)
|March 23, 2023
PubMed
Summary
This summary is machine-generated.

Pulmonary manifestations are critical in rheumatic diseases, as interstitial lung disease can be fatal. Prompt immunosuppression and plasmapheresis therapy can lead to favorable outcomes in affected patients.

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

856
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

773

Related Experiment Videos

Last Updated: Aug 5, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.0K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

856
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

773

Area of Science:

  • Rheumatology
  • Pulmonology
  • Dermatology

Context:

  • Rheumatic diseases frequently involve multiple organ systems, necessitating vigilance for pulmonary complications.
  • Interstitial lung disease (ILD) represents a severe and potentially fatal manifestation in patients with rheumatic conditions.
  • Early identification of the connection between respiratory and dermatological symptoms is crucial.

Purpose:

  • To highlight the importance of considering pulmonary involvement in rheumatic diseases.
  • To underscore the potential severity of interstitial lung disease in this context.
  • To present a case where prompt, combined immunosuppressive therapy and plasmapheresis led to a positive outcome.

Summary:

  • The case emphasizes the critical link between progressive dyspnea and new-onset skin irritation in rheumatic disease patients.
  • Immediate treatment involving immunosuppression and plasmapheresis was initiated.
  • This therapeutic approach resulted in a favorable clinical outcome, managing the severe pulmonary manifestation.

Impact:

  • This case underscores the need for a high index of suspicion for pulmonary disease in rheumatic patients presenting with respiratory symptoms.
  • It highlights the efficacy of aggressive immunosuppressive therapy combined with plasmapheresis in managing severe, potentially fatal, interstitial lung disease.
  • Early diagnosis and intervention are key to improving patient prognosis in complex rheumatic disease presentations.